Australia's largest stock trading and investment forum Australia's #1 stock forum

MSB

Click for more information

0.23%

$1.10 mesoblast limited

Pfizer Covid Pill: Gameover for MSB's treatment, page-16

First 16 Last

Share
Profile

Follow
stocksa

7,874 Posts.

622

29/01/22

11:47

Post #: 59209304
Share

Originally posted by Sorepocket ↑

Not sure I agree there will be lots of patients to treat.

By the time they have been treated with all the better cheaper alternatives, and then it is realised they did not work, it will be too late. Who’s going to be reaching for stems at US$70k a pop early on, when there’s alternatives? A few cult members only. No one else is really saying stems is the answer.

Also, let’s not forget, other companies are developing further treatments at warp speed. We are only two years into a completely new condition and look at the strides forward in that time. At best, it will be two more years before stems are approved. Imagine the advancement by other companies who are moving ahead in that time. While msb waits to fix the manufacturing quality control problems.

Even assuming the hype peddled here, hard to manufacture, and very expensive stems won’t get a look in. Novartis new this.

Better to devote resources to the cancer application. Covid was a nice announcement puff piece, but when examined under the microscope, it’s limitations were on full display.

Expand

Lets just get it approved first before you dream up more obstacles Little steps bridges to cross etc
Negative nancy

MSB Price at posting: $1.09 Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

There are more pages in this discussion • 26 more messages in this thread...

First 16 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.10		Change 0.003(0.23%)		Mkt cap ! $1.230B

Open	High	Low	Value	Volume
$1.09	$1.11	$1.07	$3.160M	2.917M

Buyers (Bids)

No.	Vol.	Price($)
29	60118	$1.10

Sellers (Offers)

Price($)	Vol.	No.
$1.10	21880	12

View Market Depth

No.	Vol.	Price($)
30	59823	1.090
22	179496	1.085
12	105128	1.080
13	171785	1.075
9	496676	1.070

Price($)	Vol.	No.
1.095	52135	9
1.100	58204	17
1.105	63263	17
1.110	118080	11
1.115	55164	6

Last trade - 13.10pm 11/07/2024 (20 minute delay)

MSB (ASX) Chart